Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharmaceutical

    Tag: pharmaceutical

    You Searched For "pharmaceutical"
    Natco Pharma gets zero USFDA observations for Chennai facility

    Natco Pharma gets zero USFDA observations for Chennai facility

    Medical Dialogues Bureau16 July 2019 9:30 AM IST
    Natco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
    The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    Medical Dialogues Bureau27 Jun 2019 9:30 AM IST
    Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
    Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene

    Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene

    Medical Dialogues Bureau26 Jun 2019 9:00 AM IST
    Bristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

    Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
    AHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Meghna A Singhania29 May 2019 2:37 PM IST
    New Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Meghna A Singhania26 May 2019 6:13 PM IST
    Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
    GSK reintroduce incentives for sales representatives

    GSK reintroduce incentives for sales representatives

    Farhat Nasim24 May 2019 9:31 AM IST
    GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
    Investors keep food firms on warning over antibiotics

    Investors keep food firms on warning over antibiotics

    Medical Dialogues Bureau21 May 2019 9:00 AM IST
    Resistance to antibiotics has been flagged as a major risk to public health and economic growth by policymakers and the investor action formed part of...
    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Medical Dialogues Bureau3 May 2019 9:15 AM IST
    Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Farhat Nasim23 April 2019 9:45 AM IST
    INDIANAPOLIS: Eli Lilly and Company today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic...
    E-platform M3 acquires majority share in Neuroglia Health Private Limited

    E-platform M3 acquires majority share in Neuroglia Health Private Limited

    Garima23 April 2019 9:30 AM IST
    New Delhi: An online platform for medical professionals, M3, Inc. of Japan has announced the acquisition of a majority stake of India based Neuroglia...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok